Recent Finacing
Recent Raise
Cellvie develops Therapeutic Mitochondria Transfer (TMT) medicines, using proprietary mitochondrial preparation and delivery methods to transplant healthy mitochondria into compromised cells, focusing initially on organ transplantation and manufacturing scale-up.
